115 related articles for article (PubMed ID: 3271647)
1. Mechanism of inhibition of hepatic bioactivation of paracetamol by dimethyl sulfoxide.
Jeffery EH; Arndt K; Haschek WM
Drug Metabol Drug Interact; 1988; 6(3-4):413-24. PubMed ID: 3271647
[TBL] [Abstract][Full Text] [Related]
2. Can acetaminophen/dimethyl sulfoxide formulation prevent accidental and intentional acetaminophen hepatotoxicity?
Algfeley SG; Al-Rejaie SS; Nagi MN
Drug Dev Res; 2019 Jun; 80(4):475-480. PubMed ID: 30701566
[TBL] [Abstract][Full Text] [Related]
3. Prevention of acetaminophen-induced hepatotoxicity by dimethyl sulfoxide.
Park Y; Smith RD; Combs AB; Kehrer JP
Toxicology; 1988 Nov; 52(1-2):165-75. PubMed ID: 3188030
[TBL] [Abstract][Full Text] [Related]
4. Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney.
Lind RC; Gandolfi AJ
Toxicol Appl Pharmacol; 1997 Jan; 142(1):201-7. PubMed ID: 9007050
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of prevention of paracetamol-induced hepatotoxicity by 3,5-dialkyl substitution. The roles of glutathione depletion and oxidative stress.
van de Straat R; de Vries J; Debets AJ; Vermeulen NP
Biochem Pharmacol; 1987 Jul; 36(13):2065-70. PubMed ID: 3606627
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the hepatotoxicity of paracetamol and its irreversible binding to rat liver microsomal protein.
Younes M; Siegers CP
Arch Toxicol; 1980 May; 45(1):61-5. PubMed ID: 6249238
[TBL] [Abstract][Full Text] [Related]
7. Hepatoprotection by dimethyl sulfoxide. III. Role of inhibition of the bioactivation and covalent bonding of chloroform.
Lind RC; Begay CK; Gandolfi AJ
Toxicol Appl Pharmacol; 2000 Jul; 166(2):145-50. PubMed ID: 10896856
[TBL] [Abstract][Full Text] [Related]
8. The toxicological relevance of paracetamol-induced inhibition of hepatic respiration and ATP depletion.
Strubelt O; Younes M
Biochem Pharmacol; 1992 Jul; 44(1):163-70. PubMed ID: 1632830
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant activity of guaiazulene and protection against paracetamol hepatotoxicity in rats.
Kourounakis AP; Rekka EA; Kourounakis PN
J Pharm Pharmacol; 1997 Sep; 49(9):938-42. PubMed ID: 9306266
[TBL] [Abstract][Full Text] [Related]
10. Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
Nakamuta M; Ohta S; Tada S; Tsuruta S; Sugimoto R; Kotoh K; Kato M; Nakashima Y; Enjoji M; Nawata H
Int J Mol Med; 2001 Nov; 8(5):553-60. PubMed ID: 11605027
[TBL] [Abstract][Full Text] [Related]
11. Antidotal effects of dimethyl sulphoxide against paracetamol-, bromobenzene-, and thioacetamide-induced hepatotoxicity.
Siegers CP
J Pharm Pharmacol; 1978 Jun; 30(6):375-7. PubMed ID: 26770
[TBL] [Abstract][Full Text] [Related]
12. Paracetamol metabolism in the isolated perfused rat liver with further metabolism of a biliary paracetamol conjugate by the small intestine.
Grafström R; Ormstad K; Moldéus P; Orrenius S
Biochem Pharmacol; 1979 Dec; 28(24):3573-9. PubMed ID: 533560
[No Abstract] [Full Text] [Related]
13. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo.
Lauterburg BH; Corcoran GB; Mitchell JR
J Clin Invest; 1983 Apr; 71(4):980-91. PubMed ID: 6833497
[TBL] [Abstract][Full Text] [Related]
14. The role of cytochrome P450IIE1 in bioactivation of acetaminophen in diabetic and acetone-treated mice.
Jeffery EH; Arndt K; Haschek WM
Adv Exp Med Biol; 1991; 283():249-51. PubMed ID: 2068990
[No Abstract] [Full Text] [Related]
15. Interaction of caffeine with acetaminophen. 1. Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with various cytochrome P450 inducing agents.
Jaw S; Jeffery EH
Biochem Pharmacol; 1993 Aug; 46(3):493-501. PubMed ID: 8347173
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine.
Tan SC; New LS; Chan EC
Toxicol Lett; 2008 Aug; 180(3):174-81. PubMed ID: 18588957
[TBL] [Abstract][Full Text] [Related]
17. Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.
Kalabis GM; Wells PG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1408-19. PubMed ID: 2262910
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of protection of lobenzarit against paracetamol-induced toxicity in rat hepatocytes.
Remirez D; Commandeur JN; Groot E; Vermeulen NP
Eur J Pharmacol; 1995 Dec; 293(4):301-8. PubMed ID: 8748682
[TBL] [Abstract][Full Text] [Related]
19. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches.
Bessems JG; Vermeulen NP
Crit Rev Toxicol; 2001 Jan; 31(1):55-138. PubMed ID: 11215692
[TBL] [Abstract][Full Text] [Related]
20. Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse.
Moldéus P
Biochem Pharmacol; 1978; 27(24):2859-63. PubMed ID: 736978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
